Cargando…
Anti-Mycobacterial Antibiotic Therapy Induces Remission in Active Paediatric Crohn’s Disease
Crohn’s disease is increasing in incidence and prevalence in younger people and is of a particularly aggressive nature. One emerging treatment targets Mycobacterium avium paratuberculosis (MAP), an organism implicated in the causation of Crohn’s disease. This study reviewed a cohort of paediatric pa...
Autores principales: | Agrawal, Gaurav, Hamblin, Harrison, Clancy, Annabel, Borody, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464505/ https://www.ncbi.nlm.nih.gov/pubmed/32722117 http://dx.doi.org/10.3390/microorganisms8081112 |
Ejemplares similares
-
Crohn’s strictures open with anti-mycobacterial antibiotic therapy: A retrospective review
por: Collyer, Rhys, et al.
Publicado: (2020) -
Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn’s Disease: A Case Series
por: Agrawal, Gaurav, et al.
Publicado: (2020) -
Profound remission in Crohn’s disease requiring no further treatment for 3–23 years: a case series
por: Agrawal, Gaurav, et al.
Publicado: (2020) -
Putting Crohn’s on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn’s Disease
por: Agrawal, Gaurav, et al.
Publicado: (2020) -
Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease
por: Agrawal, Gaurav, et al.
Publicado: (2015)